Assessing the Variability of hERG Data Generated Using a Mock Action Potential Waveform and Automated Patch Clamp Platforms - A HESI-Coordinated, Multi-Laboratory Comparison of 28 Drugs Across 3 Platforms

Poster Description

At the Safety Pharmacology Society 2024 meeting, a Health and Environmental Sciences Institute (HESI) Cardiac Safety Committee poster presented results from an international ion channel research study that assessed the variability of hERG data generated using automated patch clamp platforms (QPatch 48, Qube 384 and the SyncroPatch 384i) across four different labs. The experimental methods were standardized as much as possible, which included the use of a mock action potential voltage protocol.

The assay was used to assess the potency of twenty-eight compounds, with known proarrhythmic liability profiles, on the hERG potassium channel. While no systematic differences in the results were observed amongst the participating labs, the overall variability was estimated as 16x using random-effect meta-analysis accounting for drug- and lab-specific effects whixch is higher than that obtained using the conventional manual patch-clamp technique. Concentration verification analysis revealed that there was a correlation between the loss of compound and their LogP.

Thank you to HESI for inviting Metrion to contribute to this important work.

Assessing Variability of hERG Data

Download
Recommended Publications
Latest Publications
An Integrated Assay Platform for Mechanistic and Translational Profiling of Kv7.2/7.3 Activators

An integrated assay platform was developed to characterise the pharmacological and physiological effects of Kv7.2/7.3 activators. Combining high-throughput FLIPR thallium flux, automated voltage- and current-clamp electrophysiology, and sensory neuron recordings enabled assessment of compound potency, mechanism of action, and effects on neuronal resting membrane potential. Profiling of retigabine, flupirtine, ML213, ICA 069673, XEN1101 and opakalim demonstrated distinct pharmacological profiles across complementary assay systems. The workflow provides a mechanistic and translational approach for characterising Kv7.2/7.3 activators and their effects on neuronal excitability.

Action Potential Waveform Analysis in Human iPSC-Cardiomyocytes Enables Mechanistic Assessment of Multichannel Cardiac Effects

Optical voltage imaging of human iPSC-derived cardiomyocytes was used to assess electrophysiological effects of compounds beyond hERG inhibition. Action potential waveform analysis revealed compound-specific and concentration-dependent changes, enabling mechanistic differentiation of multichannel activity and demonstrating a human-relevant approach for translational cardiac safety assessment.

View All
magnifier
linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram